Sign in to view content

Progression of diabetic retinopathy in patients treated with 0.2 μg/day

Raymond Iezzi, MD, MS

Video
Published 2017

Related

Wieland-Khanani Port Delivery System
Mark R. Wieland, MD
Arshad M. Khanani, MD, MA, FASRS
Updates from the Field
Two years visual acuity and anatomical outcomes of patients with diabetic macular oedema treated with intravitreal aflibercept in a real life setting
Marko Lukic, MD PhD FEBO FASRS
On Demand Cases, Courses, and Papers
2019
Outcomes of Intravitreal Antivascular Endothelial Growth Factor (VEGF) Therapy for Diabetic Macular Edema in Routine Clinical Practice
John D Pitcher, MD
Annual Meeting Talks
2018

Category: Diabetic Retinopathy

See more